Roflumilast
NDC 70771-1673, Roflumilast, tablet, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1673
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208303
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1673 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROFLUMILAST250 ug/1
Pharmacologic classes
Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1673-3 | 70771167303 | 2 BLISTER PACK in 1 CARTON (70771-1673-3) / 10 TABLET in 1 BLISTER PACK (70771-1673-2) |
| 70771-1673-8 | 70771167308 | 1 BLISTER PACK in 1 CARTON (70771-1673-8) / 28 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e87287bd-eae3-46c3-9072-04800aeabf40
Use it
Look up 70771-1673 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1673 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1673. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.